OKAIROS
Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.
OKAIROS
Industry:
Biopharma Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
2007-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.okairos.com
Total Employee:
1+
Status:
Active
Contact:
41 61 270 35 35
Email Addresses:
[email protected]
Total Funding:
30.08 M USD
Technology used in webpage:
SPF Nginx ASP.NET IIS IIS 7 Starfield Technologies DOSarrest Uniregistry
Similar Organizations
Arrow Therapeutics
Arrow is a small pharmaceutical company strictly focussed on novel anti-infective discovery.
Bioceros
Bioceros provides services related to the preclinical development of monoclonal antibodies and generation protein-producing cell lines.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Fovea Pharmaceuticals
Fovea Pharmaceuticals is a French biopharmaceutical company that discovers and develops drugs for the treatment of ocular diseases.
Novexel
Novexel SA, a pharmaceutical company, engages in the discovery and development of antibacterial and antifungal agents to treat bacterial
Petnomic
Petnomic is a laboratory with the latest technology in analysis and detection of genetic mutations, specifically in dogs, cats and birds.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Quethera
Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases.
Xenova
Xenova publicly quoted biotechnology company focused on the development of novel drugs to treat cancer and addiction.
Current Advisors List
Current Employees Featured
Founder
Investors List
Versant Ventures
Versant Ventures investment in Series B - Okairos
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Okairos
BioMedPartners
BioMedPartners investment in Series A - Okairos
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Okairos
Life Sciences Partners
Life Sciences Partners investment in Series A - Okairos
Official Site Inspections
http://www.okairos.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
